Janux Therapeutics, Inc. (JANX)
16.83
+0.58
(+3.60%)
USD |
NASDAQ |
Sep 17, 15:58
Janux Therapeutics Market Cap : 1.028B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 992.21M |
| September 15, 2026 | 1.004B |
| September 14, 2026 | 1.057B |
| September 11, 2026 | 1.044B |
| September 10, 2026 | 1.080B |
| September 09, 2026 | 1.181B |
| September 08, 2026 | 1.224B |
| September 04, 2026 | 1.236B |
| September 03, 2026 | 1.209B |
| September 02, 2026 | 1.203B |
| September 01, 2026 | 1.154B |
| August 31, 2026 | 1.113B |
| August 28, 2026 | 1.101B |
| August 27, 2026 | 1.147B |
| August 26, 2026 | 1.154B |
| August 25, 2026 | 1.141B |
| August 24, 2026 | 1.136B |
| August 21, 2026 | 1.062B |
| August 20, 2026 | 1.055B |
| August 19, 2026 | 1.070B |
| August 18, 2026 | 1.036B |
| August 17, 2026 | 993.13M |
| August 14, 2026 | 984.58M |
| August 13, 2026 | 977.25M |
| August 12, 2026 | 1.018B |
| Date | Value |
|---|---|
| August 11, 2026 | 1.009B |
| August 10, 2026 | 1.002B |
| August 07, 2026 | 968.09M |
| August 06, 2026 | 983.36M |
| August 05, 2026 | 977.25M |
| August 04, 2026 | 974.80M |
| August 03, 2026 | 932.46M |
| July 31, 2026 | 923.33M |
| July 30, 2026 | 948.28M |
| July 29, 2026 | 910.55M |
| July 28, 2026 | 912.98M |
| July 27, 2026 | 947.68M |
| July 24, 2026 | 933.07M |
| July 23, 2026 | 956.81M |
| July 22, 2026 | 950.72M |
| July 21, 2026 | 989.67M |
| July 20, 2026 | 976.89M |
| July 17, 2026 | 989.67M |
| July 16, 2026 | 964.11M |
| July 15, 2026 | 975.67M |
| July 14, 2026 | 960.46M |
| July 13, 2026 | 982.37M |
| July 10, 2026 | 998.19M |
| July 09, 2026 | 1.019B |
| July 08, 2026 | 1.014B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 307.26M |
| Amgen, Inc. | 205.29B |
| Anika Therapeutics, Inc. | 281.31M |
| BioCryst Pharmaceuticals, Inc. | 2.212B |
| Imunon, Inc. | 6.299M |
Market Cap Related Metrics
| PS Ratio | 43.79 |
| Price to Book Value | 1.108 |
| Price | 16.83 |
| Earnings Yield | -9.77% |